Ensemble refinement model

PDB 5F4N|dpdb_5tp40keq

Ensemble refinement model

Multi-parameter lead optimization to give an oral CHK1 inhibitor clinical candidate: (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)

Program
PHENIX phenix.ensemble_refinement
Model type
Ensemble
Purpose
Refinement
Atoms
93,042
Residues
258
Protein chains
1
Alternate-location fraction
0%
Ligands
5UY, EDO, GOL

Evaluations

R-work
0.155
R-free
0.196
Clashscore
—

Macromolecules

The same in every model of this entry.

Entity 1
MoleculeChainsLengthOrganismUniProtDetails
Serine/threonine-protein kinase Chk1273—

Data

L0 Raw
L1 Processed
L2 Models
L3 Evaluations